crta
Hrvatska znanstvena Sekcija img
bibliografija
3 gif
 Naslovna
 O projektu
 FAQ
 Kontakt
4 gif
Pregledavanje radova
Jednostavno pretraživanje
Napredno pretraživanje
Skupni podaci
Upis novih radova
Upute
Ispravci prijavljenih radova
Ostale bibliografije
Slični projekti
 Bibliografske baze podataka

Pregled bibliografske jedinice broj: 571617

Časopis

Autori: Levanat, Sonja; Musani, Vesna; Levačić Cvok, Mirela; Sušac, Ilona; Sabol, Maja; Ozretić, Petar; Car, Diana; Eljuga, Domagoj; Eljuga, Ljerka; Eljuga, Damir
Naslov: Three novel BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia
( Three novel BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia )
Izvornik: Gene (0378-1119) 498 (2012), 2; 169-176
Vrsta rada: članak
Ključne riječi: BRCA1; BRCA2; hereditary breast/ovarian cancer; High-resolution melting analysis; Quantitative multiplex PCR of short fluorescent fragments
( BRCA1; BRCA2; hereditary breast/ovarian cancer; High-resolution melting analysis; Quantitative multiplex PCR of short fluorescent fragments )
Sažetak:
BRCA1 and BRCA2 genes from 167 candidates (145 families) were scanned for mutations. We identified 14 pathogenic point mutations in 17 candidates, 9 in BRCA1 and 5 in BRCA2. Of those, 11 have been previously described and three were novel (c.5335 C > T in BRCA1, and c.4139_4140dupTT and c.8175 G > A in BRCA2). No large deletions or duplications involving BRCA1 and BRCA2 genes were identified. No founder mutations were detected for the Croatian population. Croatia shares most of the mutations with neighboring Slovenia and also with Germany, Austria and Poland. Two common sequence variants in BRCA1, c.2077 G > A and c.4956 G > A, were found more frequently in mutation carriers compared to healthy controls. No difference in BRCA2 variants was detected between the groups. Haplotype inference showed no difference in haplotype distributions between deleterious mutation carriers and non-carriers in neither BRCA1 nor BRCA2. In silico analyses identified one BRCA1 sequence variant (c.4039A > G) and two BRCA2 variants (c.5986 G > A and c.6884 G > C) as harmful with high probability, and inconclusive results were obtained for our novel BRCA2 variant c.3864_3866delTAA. Combination of QMPSF and HRMA methods provides high detection rate and complete coverage of BRCA1/2 genes. Benefit of BRCA1/2 mutation testing is clear, since we detected mutations in young unaffected women, who will be closely monitored for breast and ovarian cancer.
Projekt / tema: 098-0982464-2461
Izvorni jezik: eng
Rad je indeksiran u
bazama podataka:
Current Contents Connect (CCC)
MEDLINE
Scopus
SCI-EXP, SSCI i/ili A&HCI
Science Citation Index Expanded (SCI-EXP) (sastavni dio Web of Science Core Collectiona)
Kategorija: Znanstveni
Znanstvena područja:
Temeljne medicinske znanosti
URL Internet adrese: http://dx.doi.org/10.1016/j.gene.2012.02.010
http://www.sciencedirect.com/science/article/pii/S0378111912002120
Broj citata:
Altmetric:
DOI: 10.1016/j.gene.2012.02.010
URL cjelovitog teksta: http://dx.doi.org/10.1016/j.gene.2012.02.010
Google Scholar: Three novel BRCA1/BRCA2 mutations in breast/ovarian cancer families in Croatia
Upisao u CROSBI: mcretnik@irb.hr (mcretnik@irb.hr), 20. Vel. 2012. u 15:47 sati



  Verzija za printanje   za tiskati


upomoc
foot_4